Dunn Keegan, Kopel Jonathan, Diab Mousab, Babb Franklyn
School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
Department of Internal Medicine, Texas Tech University Health Sciences Center, Amarillo, TX, USA.
J Community Hosp Intern Med Perspect. 2023 May 8;13(3):35-38. doi: 10.55729/2000-9666.1162. eCollection 2023.
Statins are the primary drug used to reduce morbidity and mortality for cardiovascular disease. However, many type II diabetes mellitus (T2DM) patients who are currently not on a statin would otherwise qualify. Therefore, we investigated the proportion of T2DM patients on a statin compared to the total number of T2DM patients eligible to be on a statin. We also examined potential barriers that prevent T2DM patients from being prescribed statins by physicians.
A retrospective chart study on family medicine patients was collected data on age, race, cholesterol readings, blood pressure, and whether the patient was on blood pressure medications, aspirin, and/or a statin. The information gathered was used to determine the patients' 10-year risk of cardiovascular disease. A survey was given to residents and faculty to assess the cost, side effects, and other behavioral factors had on a patients' choice to be on a statin.
Among the 706 T2DM patients, we found that a large proportion (75.2%) were both eligible and prescribed a statin according to the American Heart Association Guidelines. In addition, over 58% of the patients had a 0%-25% 10-year risk of cardiovascular disease risk. Among the 14 family medicine physicians surveyed, the fear of or history of side effects with statin medications were the greatest barriers to starting statins.
The large proportion of family medicine patients that were eligible were prescribed a statin. According to the survey, physicians Believed that the greatest barrier for a patient starting on a statin is the fear of or history of side effects with statin medications.
他汀类药物是用于降低心血管疾病发病率和死亡率的主要药物。然而，许多目前未服用他汀类药物的2型糖尿病（T2DM）患者符合用药条件。因此，我们调查了服用他汀类药物的T2DM患者在符合使用他汀类药物条件的T2DM患者总数中所占的比例。我们还研究了阻碍医生为T2DM患者开具他汀类药物的潜在障碍。
对家庭医学患者进行回顾性病历研究，收集患者的年龄、种族、胆固醇读数、血压，以及患者是否正在服用降压药、阿司匹林和/或他汀类药物。收集到的信息用于确定患者患心血管疾病的10年风险。对住院医师和教员进行了一项调查，以评估成本、副作用和其他行为因素对患者选择服用他汀类药物的影响。
在706名T2DM患者中，我们发现根据美国心脏协会指南，很大一部分患者（75.2%）既符合条件又被开具了他汀类药物。此外，超过58%的患者患心血管疾病的10年风险为0%-25%。在接受调查的14名家庭医学医生中，对他汀类药物副作用有恐惧或有副作用病史是开始使用他汀类药物的最大障碍。
符合条件的家庭医学患者中有很大一部分被开具了他汀类药物。根据调查，医生认为患者开始服用他汀类药物的最大障碍是对他汀类药物副作用的恐惧或有副作用病史。
